News

The company said that in cat allergy trial 210 patients are expected to be randomised to receive placebo or one of two regimes of the company’s T-cell vaccine.

Reportedly, the Center’s new pilot production facility is nearing completion. Following the engineering test runs and facility validation to ensure FDA quality standards are met, production of product

The agreement covers the distribution of Noveko antimicrobial masks and respirators, Microban hand sanitizers, air filters incorporating the Noveko antimicrobial filtration technology to hospitals and commercial buildings, as

Reportedly, the verbal Memorandum of Understanding (MOU) will give Wellfield an option for distributing the products in Guangdong and throughout the southern region of China. Evaluations and due

The randomized, double-blind, placebo-controlled, dose-escalation trial is expected to enroll 135 patients and will be conducted in multiple centers in several European countries. Patients with active RA, despite

The latest funding round includes £315,000 equity investment from Finance Wales and a £147,000 grant from the Welsh Assembly Government’s Single Investment Fund. It will allow the company

The notice is a routine end-of-review communication from Health Canada when additional information is needed to reach final decision on product approval. NexMed has 90 days from the

Chang Ahn, chairman and chief executive officer of Rexahn, said: “In addition to our co-development partnership with Teva, this European patent award further validates the commercial potential of

As per the agreement, Immunomedics could potentially receive up to $580m from Nycomed upon achievement of certain clinical, regulatory, and sales-based milestones. The agreement also provides the company